Prophylactic therapy for rejection after cardiac transplantation
Authors:
- James K. KirklinJKJames K. Kirklin
- Robert C. BourgeRBRobert C. Bourge
- Connie White-WilliamsCWConnie White-Williams
- David C. NaftelDNDavid C. Naftel
- Francis T. ThomasFTFrancis T. Thomas
- Judith M. ThomasJTJudith M. Thomas
- Michael G. PhillipsMPMichael G. Phillips
- 1 April 1990
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 99 (4) , 716-724
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Analysis of morbid events and risk factors for death after cardiac transplantationJACC, 1988
- Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibodyThe American Journal of Medicine, 1987
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulinThe American Journal of Medicine, 1984
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981
- Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?Proceedings of the National Academy of Sciences, 1981
- Some recent advances in cardiac pathologyHuman Pathology, 1979
- EFFECT OF ANTILYPHOCYTE-GLOBULIN POTENCY ON SURVIVAL OF CADAVER RENAL TRANSPLANTSThe Lancet, 1977
- Seven Yearsʼ Experience with Antilymphoblast Globulin for Renal Transplantation From Cadaver DonorsAnnals of Surgery, 1976